Bullous Amyloidosis Masquerading as Pseudoporphyria

Cutis. 2021 Sep;108(3):E25-E28. doi: 10.12788/cutis.0370. ABSTRACT Amyloidosis is not a singular disease but describes a group of diseases that result from abnormalities in protein folding and metabolism, leading to β-sheet polymers and amyloid fibrils. Cutaneous...

Isatuximab for the treatment of multiple myeloma

Drugs Today (Barc). 2021 Nov;57(11):665-675. doi: 10.1358/dot.2021.57.11.3343690. ABSTRACT Isatuximab is an IgG1 monoclonal antibody targeting CD38 that has received regulatory approval in combination regimens for patients with relapsed/refractory multiple myeloma....

Belantamab mafodotin for the treatment of multiple myeloma

Drugs Today (Barc). 2021 Nov;57(11):653-663. doi: 10.1358/dot.2021.57.11.3319146. ABSTRACT Multiple myeloma is the second most common hematologic malignancy worldwide. Despite the growing number of available therapeutic options and advances in the treatment since the...